Fremanezumab for the Preventive Treatment of Migraine: Subgroup Analysis by Number of Prior Preventive Treatments with Inadequate Response

OBJECTIVE: To evaluate the efficacy of monthly or quarterly fremanezumab in patients with chronic migraine or episodic migraine and documented inadequate response to 2, 3, or 4 classes of prior migraine preventive medications. METHODS: This is an exploratory analysis of a randomized, double-blind, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Pazdera, Ladislav, Cohen, Joshua M, Ning, Xiaoping, Campos, Verena Ramirez, Yang, Ronghua, Pozo-Rosich, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411464/
https://www.ncbi.nlm.nih.gov/pubmed/33990144
http://dx.doi.org/10.1177/03331024211008401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411464/
https://www.ncbi.nlm.nih.gov/pubmed/33990144
http://dx.doi.org/10.1177/03331024211008401

Ejemplares similares